MedTrace Logo

Efficiency of Tadalafil for Management of Female Sexual Dysfunction

NCT05266651 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2022-03-04

No results posted yet for this study

Summary

comparative study between tadalafil versus placebo effect for the management of circumsized female

Conditions

  • Sexual Dysfunction

Interventions

DRUG

Tadalafil 5mg

oral tablets for one month duration

DRUG

Placebo

oral tablets for one month duration

Sponsors & Collaborators

  • Kasr El Aini Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-10
Primary Completion
2022-05-31
Completion
2022-05-31

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05266651 on ClinicalTrials.gov